Metazosin
 | |
| Nazivi | |
|---|---|
| IUPAC naziv 1-[4-(4-Amino-6,7-dimetoksihinazolin-2-il)piperazin-1-il]-2-metoksipropan-1-on | |
| Drugi nazivi Kenosin | |
| Identifikacija | |
| |
3D model (Jmol) |
|
| ChemSpider |
|
| |
| UNII |
|
SMILES
| |
| Svojstva | |
| C18H25N5O4 | |
| Molarna masa | 375,43 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Metazosin je antihipertensivni antagonist α1-adrenergičnog receptora.[3][4]
Reference
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Trcka, V; König, J; Mácová, S; Smíd, M; Helfert, I; Votavová, M; Remesová, J; Nezádalová, E (1990). „Pharmacology of a new antihypertensive agent, metazosin (Kenosin)”. Ceskoslovenska Farmacie. 39 (6): 266—74. PMID 1981860.
- ^ Lapka, R; Rejholec, V; Sechser, T; Peterková, M; Smíd, M (1989). „Interspecies pharmacokinetic scaling of metazosin, a novel alpha-adrenergic antagonist”. Biopharmaceutics & Drug Disposition. 10 (6): 581—9. PMID 2575403. doi:10.1002/bdd.2510100607.
- п
- р
- у
Adrenergici
| |||||
|
| |||||||||||||||||||
Drugi | |||||||
|---|---|---|---|---|---|---|---|
| |||||||
